Judith D Goldberg Selected Research

ruxolitinib

12/2018	Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms.
1/2017	A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Judith D Goldberg Research Topics

Disease

28	Neoplasms (Cancer) 01/2021 - 08/2002
15	Breast Neoplasms (Breast Cancer) 11/2019 - 10/2004
9	Lung Neoplasms (Lung Cancer) 09/2020 - 08/2002
7	Primary Myelofibrosis (Myelosclerosis) 01/2019 - 04/2013
5	Polycythemia Vera 12/2022 - 08/2014
5	Essential Thrombocythemia 12/2022 - 08/2014
5	Neoplasm Metastasis (Metastasis) 01/2016 - 10/2003
3	Inflammation (Inflammations) 01/2023 - 01/2007
3	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2021 - 09/2012
3	Acoustic Neuroma (Acoustic Neurinoma) 01/2021 - 09/2012
3	Familial Dysautonomia (Riley Day Syndrome) 03/2009 - 08/2005
2	Melanoma (Melanoma, Malignant) 11/2022 - 03/2014
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 09/2011
2	Multiple Sclerosis 01/2020 - 10/2019
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 10/2019 - 08/2014
2	Proteinuria 01/2019 - 01/2018
2	Triple Negative Breast Neoplasms 01/2017 - 03/2014
2	Herpes Zoster 07/2013 - 05/2013
2	Fibrosis (Cirrhosis) 04/2013 - 01/2007
2	Adenocarcinoma 07/2010 - 01/2006
1	Pathologic Constriction (Stenosis) 01/2023
1	Crohn Disease (Crohn's Disease) 01/2023
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023
1	Acute Kidney Injury (Acute Renal Failure) 06/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2021
1	Lymphoma (Lymphomas) 06/2021
1	Endometriosis 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Meningioma (Meningiomas) 01/2021
1	Neurilemmoma (Schwannoma) 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 09/2020
1	Emphysema 09/2020
1	Progressive Multifocal Leukoencephalopathy 10/2019
1	Sudden Infant Death (SID) 10/2019
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2019
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2019
1	Disease Progression 01/2019
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2019
1	Blast Crisis (Blast Phase) 12/2018
1	Lupus Nephritis 01/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 02/2017

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 06/2022 - 10/2007
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2008
3	InterferonsIBA 12/2022 - 01/2016
3	Everolimus FDA Link 01/2021 - 01/2014
3	Hormones (Hormone)IBA 01/2021 - 11/2012
3	CytokinesIBA 01/2016 - 12/2012
3	Messenger RNA (mRNA)IBA 03/2009 - 08/2005
2	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2022 - 10/2019
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 01/2014
2	fresolimumabIBA 11/2019 - 01/2018
2	CreatinineIBA 01/2019 - 01/2018
2	lestaurtinibIBA 01/2019 - 01/2015
2	ruxolitinibIBA 12/2018 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 11/2010
2	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 03/2014
2	PanobinostatIBA 01/2017 - 04/2013
2	Histone Deacetylase InhibitorsIBA 01/2017 - 04/2013
2	Phosphotransferases (Kinase)IBA 01/2015 - 11/2010
2	Imiquimod (Aldara)FDA LinkGeneric 10/2014 - 12/2012
2	AutoantibodiesIBA 07/2014 - 05/2010
2	TOR Serine-Threonine KinasesIBA 03/2014 - 01/2014
2	VaccinesIBA 07/2013 - 05/2013
2	Endothelin Receptors (Endothelin Receptor)IBA 06/2013 - 09/2010
2	AsbestosIBA 01/2012 - 01/2007
2	I-kappa B KinaseIBA 03/2009 - 02/2008
2	Benzo(a)pyreneIBA 01/2007 - 08/2002
1	IodineIBA 01/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	NivolumabIBA 11/2022
1	IpilimumabIBA 11/2022
1	insulin-like growth factor binding protein-related protein 1IBA 06/2022
1	Tissue Inhibitor of Metalloproteinase-2IBA 06/2022
1	GonadotropinsIBA 01/2021
1	luprolide acetate gel depot FDA Link 01/2021
1	Cholinesterases (Cholinesterase)IBA 01/2021
1	Leuprolide (Lupron)FDA LinkGeneric 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 09/2020
1	Metalloproteases (Metalloproteinases)IBA 09/2020
1	nitazoxanide (NTZ)FDA Link 01/2020
1	peginterferon alfa-2a (Pegasys)FDA Link 10/2019
1	Natalizumab (Tysabri)FDA Link 10/2019
1	zonulinIBA 01/2019
1	SteroidsIBA 01/2019
1	Decitabine FDA Link 12/2018
1	exemestane (Aromasin)FDA Link 02/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2018
1	AlbuminsIBA 01/2018
1	Serum AlbuminIBA 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 02/2017
1	Topoisomerase InhibitorsIBA 02/2017

Therapy/Procedure

12	Radiotherapy 11/2019 - 10/2004
10	Therapeutics 12/2022 - 01/2011
3	Segmental Mastectomy (Lumpectomy) 01/2016 - 06/2007
2	Hematopoietic Stem Cell Transplantation 01/2023 - 08/2014
2	Drug Therapy (Chemotherapy) 06/2021 - 04/2016
1	Adjuvant Chemotherapy 01/2018